I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Richmond, Gary J
155
results:
Search for persons
X
Format
Online (154)
Print (1)
Mediatypes
Books (1)
E-Books (4)
Articles (Online) (84)
OpenAccess-fulltext (66)
Sorted by: Relevance
Sorted by: Year
?
1
Efficacy and safety of the novel capsid inhibitor lenacapav..:
Ogbuagu, Onyema
;
Segal-Maurer, Sorana
;
Ratanasuwan, Winai
...
The Lancet HIV. 10 (2023) 8 - p. e497-e505 , 2023
Link:
https://doi.org/10.1016/..
?
2
1596. Efficacy and Safety of Long-Acting Subcutaneous Lenac..:
Ogbuagu, Onyema
;
DeJesus, Edwin
;
Berhe, Mezgebe
...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023
Link:
https://doi.org/10.1093/..
?
3
Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Mont..:
Overton, Edgar T
;
Richmond, Gary
;
Rizzardini, Giuliano
...
Clinical Infectious Diseases. 76 (2023) 9 - p. 1646-1654 , 2023
Link:
https://doi.org/10.1093/..
?
4
Long-acting cabotegravir and rilpivirine for HIV-1 suppress..:
Mills, Anthony
;
Richmond, Gary J.
;
Newman, Cheryl
...
AIDS. 36 (2021) 2 - p. 195-203 , 2021
Link:
https://doi.org/10.1097/..
?
5
Efficacy, Safety, and Durability of Long-Acting Cabotegravi..:
Smith, Graham H R
;
Henry, W Keith
;
Podzamczer, Daniel
...
Open Forum Infectious Diseases. 8 (2021) 9 - p. , 2021
Link:
https://doi.org/10.1093/..
?
6
116. Antiviral Activity and Safety of Long-acting Cabotegra..:
Mills, Anthony
;
Richmond, Gary J
;
Newman, Cheryl
...
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S186-S187 , 2020
Link:
https://doi.org/10.1093/..
?
7
Long-acting cabotegravir and rilpivirine dosed every 2 mont..:
Overton, Edgar T
;
Richmond, Gary
;
Rizzardini, Giuliano
...
The Lancet. 396 (2020) 10267 - p. 1994-2005 , 2020
Link:
https://doi.org/10.1016/..
?
8
Intraspecific variation in thermal acclimation and toleranc..:
Tonione, Maria Adelena
;
Cho, So Mi
;
Richmond, Gary
..
Ecology and Evolution. 10 (2020) 11 - p. 4749-4761 , 2020
Link:
https://doi.org/10.1002/..
?
9
Long-Acting Injectable Cabotegravir + Rilpivirine for HIV M..:
Rizzardini, Giuliano
;
Overton, Edgar T.
;
Orkin, Chloe
...
JAIDS Journal of Acquired Immune Deficiency Syndromes. 85 (2020) 4 - p. 498-506 , 2020
Link:
https://doi.org/10.1097/..
?
10
Experiences with long acting injectable ART: A qualitative ..:
Kerrigan, Deanna
;
Mantsios, Andrea
;
Gorgolas, Miguel
...
PLOS ONE. 13 (2018) 1 - p. e0190487 , 2018
Link:
https://doi.org/10.1371/..
?
11
Forty-eight-Week Safety and Efficacy On-Treatment Analysis ..:
Emu, Brinda
;
Fessel, W Jeffery
;
Schrader, Shannon
...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S38-S39 , 2017
Link:
https://doi.org/10.1093/..
?
12
Sword 1 and 2: Subgroup Analysis of 48 Week Results by Age,..:
Walmsley, Sharon
;
Richmond, Gary
;
Bredeek, Fritz
...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S427-S427 , 2017
Link:
https://doi.org/10.1093/..
?
13
Primary Efficacy Endpoint and Safety Results of Ibalizumab ..:
Lalezari, Jacob
;
Fessel, W. Jeffery
;
Schrader, Shannon
...
Open Forum Infectious Diseases. 3 (2016) suppl_1 - p. , 2016
Link:
https://doi.org/10.1093/..
?
14
Joseph Ransdell and the Communicational Process of Philosop..:
Richmond, Gary
;
Udell, Ben
Transactions of the Charles S. Peirce Society: A Quarterly Journal in American Philosophy. 49 (2013) 4 - p. 457-466 , 2013
Link:
https://www.jstor.org/st..
?
15
Safety and Efficacy of Dolutegravir in Treatment-Experience..:
Eron, Joseph J.
;
Clotet, Bonaventura
;
Durant, Jacques
...
The Journal of Infectious Diseases. 207 (2013) 5 - p. 740-748 , 2013
Link:
http://dx.doi.org/10.109..
1-15